April 16th 2025
Introducing a new series highlighting ways pharma companies can up their game in winning earned media—and ultimately deliver greater impact and value from their messaging.
Assessing HCP-Visit Fallout: COVID’s Ultimate Impact on New Drug Entrants
September 9th 2022Tracking the pandemic’s influence on brand awareness and prescribing efforts in light of decline in physician visits and fewer diagnoses—and what these dynamics, still unsettled post-pandemic, might mean for future launches.